PeƱalosa, Jovelyn U.
HRN: 18-51-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
MUPIROCIN 2%, 15G (TUBE)
02/19/2026
02/26/2026
SKIN
2%
BID
LSTCS
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines